share_log

Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2

Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2

Canaccord Genuity 假设 TheraTechnologies 处于停滞状态,宣布目标
Benzinga ·  2023/07/03 09:02

Canaccord Genuity analyst Edward Nash assumes Theratechnologies (NASDAQ:THTX) with a Hold rating and announces Price Target of $2.

Canaccel Genuity分析师爱德华·纳什假设Therattech(纳斯达克:THTX)持有评级,并宣布目标价为2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发